Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion

Journal of Clinical Investigation

Volumn 109, Issue 5, 2002, Pages 585-593

  Miyata, Toshio ^a   Inagi, Reiko ^a   Nangaku, Masaomi ^b   Imasawa, Toshiyuki ^a   Sato, Masahiro ^a   Izuhara, Yuko ^a   Suzuki, Daisuke ^a   Yoshino, Atsusi ^a   Onogi, Hiroshi ^a   Kimura, Minoru ^a   Sugiyama, Satoshi ^c   Kurokawa, Kiyoshi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G; MEGSIN; PLASMIN; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; IMMUNE COMPLEX DEPOSITION; IN VITRO STUDY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MESANGIUM CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE;

EID: 0036192938     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0214336     Document Type: Article

References (30)

1. A mesangium-predominant gene, megsin, is a new serpin up-regulated in IgA nephropathy
2. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases
3. Specific tissue distribution of megsin, a novel serpin, in the glomerulus and its up-regulation in IgA nephropathy
4. Cloning of rodent megsin revealed its up-regulation in mesangioproliferative nephritis
5. Accumulation of β-amyloid fibrils in pancreas of transgenic mice
6. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice
7. Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice
8. Role of oxidants and proteases in glomerular injury
9. Proteinases and glomerular matrix turnover
10. Proteolytic enzymes as mediators of glomerular injury
11. High glucose concentration causes a decrease in mesangium degradation. A factor in the pathogenesis of diabetic nephropathy
12. Proteinases and the glomerulus: Their role in glomerular diseases
13. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis
14. A slice of PAI
15. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
16. Mechanism of antinephritic effect of proteinase inhibitors in experimental anti-GBM glomerulopathy
17. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation
18. Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats
19. Glomerular mesangial cells
20. Evidence for immunoglobulin Fc receptor-mediated prostaglandin 2 and platelet-activating factor formation by cultured rat mesangial cells
21. Regulation of Fc receptors for IgG on cultured rat mesangial cells
22. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: Possible role in diabetic nephropathy
23. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade
24. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis
25. Of mice and men. The function of plasminogen activator inhibitors (PAIs) in vivo
26. Human ovalbumin serpin evolution: Phylogenic analysis, gene organization, and identification of new PI8-related genes suggest that two interchromosomal and several intrachromosomal duplications generated the gene clusters at 18q21-q23 and 6p25
27. The aging kidney: Insights from experimental studies
28. Mesangial lesions and focal glomerulosclerosis in the aging rat
29. Age-related nephropathy in laboratory rats